| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |